Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
Ying Tang, Shenglan Li, Jiahui Hu, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Xuhui Bao, Yongjun Liang, Hanman Chang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases
Eunhye Ji, Sahmin Lee
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5770-5770
Open Access | Times Cited: 59
Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
Emily Punch, Justus Klein, Patrick Diaba‐Nuhoho, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 58
Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies
Rahagir Salekeen, Abu Nasim Haider, Fouzia Akhter, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2022) Vol. 14, pp. 200143-200143
Open Access | Times Cited: 42
Comprehensive view of macrophage autophagy and its application in cardiovascular diseases
Wanqian Pan, Jun Zhang, Lei Zhang, et al.
Cell Proliferation (2023) Vol. 57, Iss. 1
Open Access | Times Cited: 20
Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE study
Nicola Ferri, Massimiliano Ruscica, Daniela Coggi, et al.
Atherosclerosis (2020) Vol. 309, pp. 39-46
Open Access | Times Cited: 40
Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance
C. Macchi, C. Favero, Alessandro Ceresa, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 40
Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes
Li Song, Xiaoxiao Zhao, Runzhen Chen, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 26
PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
Rahayu Zulkapli, S. Muid, Seok Mui Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5098-5098
Open Access | Times Cited: 14
Exosomal miR‐512‐3p derived from mesenchymal stem cells inhibits oxidized low‐density lipoprotein‐induced vascular endothelial cells dysfunction via regulating Keap1
Sisi Chen, Heng Zhou, Bofang Zhang, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 6, pp. 1-11
Closed Access | Times Cited: 29
The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair
Velimir Altabas, Lora Stanka Kirigin Biloš
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2663-2663
Open Access | Times Cited: 17
The LEPIS-HuR-TMOD4 axis regulates hepatic cholesterol homeostasis and accelerates atherosclerosis
Ping LYu, Hangyu Pan, Kexin Hu, et al.
Atherosclerosis (2024) Vol. 393, pp. 117554-117554
Open Access | Times Cited: 3
The Impact of PCSK9 on Risk Factors for Ischemic Stroke and Potential Mechanisms
Zehua He, Mingtian Lu, Zhejing Ding, et al.
American Journal of Molecular Biology (2025) Vol. 15, Iss. 01, pp. 110-122
Open Access
Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study
Jie Shi, Weiwei Zhang, Yixin Niu, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 20
Adoptive transfer of metabolically reprogrammed macrophages for atherosclerosis treatment in diabetic ApoE−/- mice
Tingting Wang, Yan Dong, Li Yao, et al.
Bioactive Materials (2022) Vol. 16, pp. 82-94
Open Access | Times Cited: 11
miR‐148a‐3p mitigation of coronary artery disease through PCSK9/NF‐κB inhibition of vascular endothelial cell injury
Jiong Tang, Menghuai Ma, Fan Liu, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 11
Closed Access | Times Cited: 2
Molecular and cellular biology of PCSK9: impact on glucose homeostasis
Sègbédé E. R. Tchéoubi, Casimir D. Akpovi, Frédérique Coppée, et al.
Journal of drug targeting (2022) Vol. 30, Iss. 9, pp. 948-960
Closed Access | Times Cited: 11
Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population
Yiming Wu, Jie Shi, Qing Su, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 10
PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis
Ghaidaa Raheem Lateef Al‐Awsi, Methaq Hadi Lafta, Hamzah H. Kzar, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109318-109318
Closed Access | Times Cited: 10
Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-Specific Differences in Inflammation, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice
Dániel Kucsera, Viktória É. Tóth, Dorottya Gergő, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 13
Effect of Triglyceride-Glucose Indices and Circulating PCSK9-Associated Cardiovascular Risk in STEMI Patients with Primary Percutaneous Coronary Artery Disease: A Prospective Cohort Study
Xiaoxiao Zhao, Li Song, Jiannan Li, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 269-282
Open Access | Times Cited: 5
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
Elena M. Yubero‐Serrano, Juan F. Alcalá‐Díaz, Francisco M. Gutierrez‐Mariscal, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Association between circulatory microRNA-218 expression, serum PCSK9 levels, inflammatory markers, and monocyte subsets in coronary artery disease patients: impact of statin therapy
Dina A. Desouky, Nahla Nosair, Dalia Elsayed Sherif, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Multiomic integration analysis identifies atherogenic metabolites mediating between novel immune genes and cardiovascular risk
Robert Carreras‐Torres, Iván Galván‐Femenía, Xavier Farré, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
PCSK9 and its relationship with HMGB1, TLR4, and TNFα in non-statin and statin-treated coronary artery disease patients
Dina A. Desouky, Nahla Nosair, Mohamed Kamal Salama, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top